Work

Pharmacogenetic dosing by UGT1A1 genotype as first-line therapy for advanced small-bowel adenocarcinoma: A North Central Cancer Treatment Group (NCCTG) trial.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.4_suppl.314

Authors: Robert R. McWilliams, Michelle R. Mahoney, Benjamin T. Marchello, Aminah Jatoi, Keith D. Krewer, Matthew M. Ames, Daniel Jay Schneider, Grant R. Seeger, Rex B. Mowat, Steven R. Alberts, Matthew P. Goetz

Institutions: Mayo Clinic, St. Luke's Hospital

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589529884

Cites:

Cited by: 10

Related to: 10